TRACON Pharmaceuticals Executives

TCONDelisted Stock  USD 1.60  0.55  52.38%   
TRACON Pharmaceuticals employs about 17 people. The company is managed by 6 executives with a total tenure of roughly 11 years, averaging almost 1.0 years of service per executive, having 2.83 employees per reported executive. Analysis of TRACON Pharmaceuticals' management performance can provide insight into the firm performance.
Bonne Adams  President
Senior Vice President - Clinical Operations
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

TRACON Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.1978) % which means that it has lost $0.1978 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7701) %, meaning that it created substantial loss on money invested by shareholders. TRACON Pharmaceuticals' management efficiency ratios could be used to measure how well TRACON Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

TRACON Pharmaceuticals Workforce Comparison

TRACON Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 811. TRACON Pharmaceuticals holds roughly 17.0 in number of employees claiming about 2.1% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.14 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (32.12) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $32.12.

TRACON Pharmaceuticals Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TRACON Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on TRACON Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, TRACON Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

TRACON Pharmaceuticals Notable Stakeholders

A TRACON Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as TRACON Pharmaceuticals often face trade-offs trying to please all of them. TRACON Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting TRACON Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Bonne AdamsSenior Vice President - Clinical OperationsProfile
Shahe GarabedianSenior AssuranceProfile
Pharmd PharmDVP AffairsProfile
Ya HuangExecutive ProgrammingProfile
James FreddoChief OfficerProfile
MS CPAChief OfficerProfile

About TRACON Pharmaceuticals Management Performance

The success or failure of an entity such as TRACON Pharmaceuticals often depends on how effective the management is. TRACON Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TRACON management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TRACON management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer in the United States. TRACON Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in San Diego, California. Tracon Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.

TRACON Pharmaceuticals Workforce Analysis

Traditionally, organizations such as TRACON Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare TRACON Pharmaceuticals within its industry.

TRACON Pharmaceuticals Manpower Efficiency

Return on TRACON Pharmaceuticals Manpower

Revenue Per Employee708.5K
Revenue Per Executive2M
Net Loss Per Employee211.1K
Net Loss Per Executive598K
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in TRACON Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.